Drug Database
Back to search

Poland· PL-100247915

Peritol

A cyproheptadine product containing cyproheptadini hydrochloridum, registered in Poland by Egis Pharmaceuticals PLC. The same ATC class is registered in 10 of our 19 countries.

ATC R06AX02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedPeritolATCR06AX02REGISTER NO.PL-100247915PACKS LISTED10CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cyproheptadini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cyproheptadine is registered in 10 of 19 countries.

Countries holding a registration under ATC R06AX02 (cyproheptadine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search cyproheptadine products by name

Cyproheptadine · ATC R06AX02

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Germany
  • Japan
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Cyproheptadini hydrochloridum
Manufacturer
Egis Pharmaceuticals PLC
Country
Poland (PL)
ATC code
R06AX02
ATC class
Cyproheptadine
Defined daily dose
12 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 10

  • gtin
    05995327176994
  • gtin
    05995327177007
  • gtin
    05995327177052
  • gtin
    05995327177069
  • gtin
    05995327177083
  • gtin
    05995327177090
  • gtin
    05995327177106
  • gtin
    05995327177113
  • gtin
    05909990156917
  • gtin
    05995327176987

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

327 interactions on record for cyproheptadine.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cyproheptadine against other medicinesHow interaction checks work

Cyproheptadine · interactions on record

327 records

  • 9 severe
  • 316 moderate
  • 2 minor

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • Sodium oxybateN01AX11severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cyproheptadine in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cyproheptadine products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Czechia · Peritol
  • Germany · Peritol
  • Spain · Periactin
  • France · Periactine
  • Hungary · Peritol
  • Italy · Periactin
  • Portugal · Viternum
  • Slovakia · Peritol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2daeed44-a270-4003-80e7-04215ddcc287
GET /v1/drugs/2daeed44-a270-4003-80e7-04215ddcc287?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "4 mg",
  "packaging": "05909990156917 ¦ Rp ¦ 45912\n20 tabl.\n05995327176987 ¦ Rp ¦ Skasowane ¦ 134436\n30 tabl.\n05995327176994 ¦ Rp ¦ Skasowane ¦ 134437\n40 tabl.\n05995327177007 ¦ Rp ¦ Skasowane ¦ 134438\n50 tabl.\n05995327177052 ¦ Rp ¦ Skasowane ¦ 134439\n60 tabl.\n05995327177069 ¦ Rp ¦ Skasowane ¦ 134440\n70 tabl.\n05995327177083 ¦ Rp ¦ Skasowane ¦ 134441\n80 tabl.\n05995327177090 ¦ Rp ¦ Skasowane ¦ 134442\n90 tabl.\n05995327177106 ¦ Rp ¦ Skasowane ¦ 134443\n100 tabl.\n05995327177113 ¦ Rp ¦ Skasowane ¦ 134444\n120 tabl.",
  "substance": "Cyproheptadini hydrochloridum 4 mg",
  "common_name": "Cyproheptadini hydrochloridum",
  "pl_product_id": "100247915",
  "pozwolenie_nr": "01569",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about cyproheptadine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console